HIT:NYE-Health In Tech, Inc. Class A Common Stock (USD)

COMMON STOCK | Scientific & Technical Instruments |

Last Closing

USD 5.1

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.25M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Scientific & Technical Instruments

Symbol Name Price(Change) Market Cap
GRMN Garmin Ltd

+0.31 (+0.15%)

USD 41.36B
KEYS Keysight Technologies Inc

-0.51 (-0.31%)

USD 28.27B
COHR Coherent Inc

+1.35 (+1.38%)

USD 17.20B
BMI Badger Meter Inc

-0.85 (-0.39%)

USD 6.40B
VNT Vontier Corp

+0.29 (+0.79%)

USD 5.95B
ST Sensata Technologies Holding N..

+0.20 (+0.73%)

USD 4.07B
BKSY Blacksky Technology Inc

-0.30 (-2.81%)

USD 0.33B
VPG Vishay Precision Group Inc

-0.26 (-1.12%)

USD 0.31B
FTV Fortive Corp

+0.01 (+0.01%)

N/A
TDY Teledyne Technologies Incorpor..

+2.85 (+0.61%)

N/A

ETFs Containing HIT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Scientific & Technical Instruments) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike